Cite
MLA Citation
Sten Myrehaug et al.. “92: [177Lu]Lu-Dota-Tate as First-Line Therapy for Patients with Grade 2 and 3 Advanced Gastroenteropancreatic Neuroendocrine Tumours (GEP-NETS): The NETTER-2 Study.” Radiotherapy and oncology, vol. 174, n.d., pp. S40–S41. http://access.bl.uk/ark:/81055/vdc_100166746952.0x000031